Literature DB >> 15340445

An Apollon vista of death and destruction.

Seamus J Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15340445     DOI： 10.1038/ncb0904-804

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  9 in total

1.  Apollon/Bruce is upregulated by Humanin.

Authors:  Yuichi Hashimoto; Yuji Takeshita; Mikihiko Naito; Hiroyuki Uchino; Masaaki Matsuoka
Journal:  Mol Cell Biochem       Date:  2014-08-20       Impact factor: 3.396

2.  Identification of BIRC6 as a novel intervention target for neuroblastoma therapy.

Authors:  Fieke Lamers; Linda Schild; Jan Koster; Frank Speleman; Ingrid Øra; Ellen M Westerhout; Peter van Sluis; Rogier Versteeg; Huib N Caron; Jan J Molenaar
Journal:  BMC Cancer       Date:  2012-07-12       Impact factor: 4.430

3.  The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib.

Authors:  Kevin R Kelly; Jeffrey Ecsedy; Ernest Medina; Devalingam Mahalingam; Swaminathan Padmanabhan; Steffan T Nawrocki; Francis J Giles; Jennifer S Carew
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

Review 4.  Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.

Authors:  Darren Finlay; Peter Teriete; Mitchell Vamos; Nicholas D P Cosford; Kristiina Vuori
Journal:  F1000Res       Date:  2017-04-27

5.  MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide.

Authors:  Zhiguo Wang; Zehui Fang; Runzhang Lu; Hongli Zhao; Tiejun Gong; Dong Liu; Luojia Hong; Jun Ma; Mei Zhang
Journal:  Oncol Res       Date:  2019-04-08       Impact factor: 5.574

6.  BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis.

Authors:  Chrystelle L Vilfranc; Li-Xiao Che; Krushna C Patra; Liang Niu; Olugbenga Olowokure; Jiang Wang; Shimul A Shah; Chun-Ying Du
Journal:  World J Hepatol       Date:  2021-03-27

7.  BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation.

Authors:  Anna M Schläfli; Bruce E Torbett; Martin F Fey; Mario P Tschan
Journal:  Exp Hematol Oncol       Date:  2012-09-04

8.  The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.

Authors:  Sze Ue Iris Luk; Hui Xue; Hongwei Cheng; Dong Lin; Peter W Gout; Ladan Fazli; Colin C Collins; Martin E Gleave; Yuzhuo Wang
Journal:  Oncotarget       Date:  2014-08-30

9.  MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis.

Authors:  Zhiguo Wang; Hong Luo; Zehui Fang; Yanling Fan; Xiaojuan Liu; Yujing Zhang; Shuping Rui; Yafeng Chen; Luojia Hong; Jincheng Gao; Mei Zhang
Journal:  BMB Rep       Date:  2018-09       Impact factor: 4.778
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.